There are medications available to treat neocoronavirus pneumonia, such as PF-07321332, ritonavir tablets, ambavizumab, and lomivizumab injection. However, these drugs are not the current effective drugs for treating neocoronavirus pneumonia. The latest protocol for new coronavirus pneumonia recommends that the combination of PF-07321332 and ritonavir tablets can be used to treat adults and adolescents with mild and common forms of the disease with an associated risk of progression to severe forms within 5 days of onset. The combination of ambavizumab and lomivizumab injection can also be used to treat patients with mild and common forms. Intravenous COVID-19 human immunoglobulin and recovery plasma for convalescents can be used to treat patients with early stage risk factors, rapid progression, and high viral loads. Novel coronavirus pneumonia is a complex disease and should be treated comprehensively by a medical professional according to the condition. Tips] In this article, “new coronavirus pneumonia” and “new coronavirus pneumonia” have been renamed to “new coronavirus infection” on December 26, 2022, as announced by the National Health Commission.